JP2025505294A5 - - Google Patents
Info
- Publication number
- JP2025505294A5 JP2025505294A5 JP2024548458A JP2024548458A JP2025505294A5 JP 2025505294 A5 JP2025505294 A5 JP 2025505294A5 JP 2024548458 A JP2024548458 A JP 2024548458A JP 2024548458 A JP2024548458 A JP 2024548458A JP 2025505294 A5 JP2025505294 A5 JP 2025505294A5
- Authority
- JP
- Japan
- Prior art keywords
- tryptophan
- pharmaceutically acceptable
- pharmaceutical
- hydroxytryptophan
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102022103658.8 | 2022-02-16 | ||
| DE102022103658.8A DE102022103658A1 (de) | 2022-02-16 | 2022-02-16 | Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer |
| PCT/EP2023/053129 WO2023156275A1 (en) | 2022-02-16 | 2023-02-08 | Pharmaceutical composition and medicament comprising l-tryptophan, l-5-hydroxytryptophan and a peripheral degradation inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505294A JP2025505294A (ja) | 2025-02-21 |
| JP2025505294A5 true JP2025505294A5 (cg-RX-API-DMAC10.html) | 2026-02-03 |
Family
ID=85221827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548458A Pending JP2025505294A (ja) | 2022-02-16 | 2023-02-08 | Ｌ－トリプトファン、ｌ－５－ヒドロキシトリプトファンおよび末梢分解阻害剤を含む医薬組成物および医薬 |
Country Status (10)
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4126672A (en) | 1976-02-04 | 1978-11-21 | Hoffmann-La Roche Inc. | Sustained release pharmaceutical capsules |
| US4167558A (en) | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
| US4140755A (en) | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
| CH652025A5 (de) | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
| DE3642668A1 (de) | 1986-12-13 | 1988-06-23 | Kamprad Joachim | Schmerzmittel fuer menschen |
| FR2654931B1 (fr) | 1989-11-24 | 1993-08-27 | Trouillas Paul | Compositions pharmaceutiques possedant une activite sur l'ataxie et les troubles de l'equilibre, cerebelleux ou autres, de toutes origines, comprenant l'association de l-5-hydroxytryptophane et de carbidopa. |
| US6207699B1 (en) * | 1999-06-18 | 2001-03-27 | Richard Brian Rothman | Pharmaceutical combinations for treating obesity and food craving |
| EP1751312A4 (en) * | 2004-05-21 | 2010-01-27 | Univ Duke | POLYMORPHISM IN TRYPTOPHAN HYDROXYLASE 2 REGULATING BRAIN SEROTONIN SYNTHESIS |
| DE102004039196B4 (de) | 2004-08-12 | 2008-07-31 | Dr.Kamprad Kg | Neue Formulierung für L-Tryptophan |
| US20060257469A1 (en) * | 2005-04-05 | 2006-11-16 | Bulka Yochanan R | Enhanced indoleamine and catecholamine bio-availability via catechin inhibition of L-Dopa decarboxylase |
| ES2948788T3 (es) * | 2018-01-29 | 2023-09-19 | Univ Duke | Composiciones y métodos para mejorar la biodisponibilidad del 5-hidroxitriptófano |
-
2022
- 2022-02-16 DE DE102022103658.8A patent/DE102022103658A1/de active Pending
-
2023
- 2023-02-08 US US18/839,100 patent/US20250161270A1/en active Pending
- 2023-02-08 KR KR1020247030751A patent/KR20240152875A/ko active Pending
- 2023-02-08 AU AU2023222362A patent/AU2023222362A1/en active Pending
- 2023-02-08 CA CA3243635A patent/CA3243635A1/en active Pending
- 2023-02-08 EP EP23704337.7A patent/EP4479027A1/en active Pending
- 2023-02-08 JP JP2024548458A patent/JP2025505294A/ja active Pending
- 2023-02-08 WO PCT/EP2023/053129 patent/WO2023156275A1/en not_active Ceased
- 2023-02-08 CN CN202380022428.3A patent/CN118871096A/zh active Pending
-
2024
- 2024-08-14 MX MX2024009966A patent/MX2024009966A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2572768B2 (ja) | レボドパメチルエステルを有効成分とするパ−キンソン病治療剤 | |
| JP2022153638A5 (cg-RX-API-DMAC10.html) | ||
| JP2015528471A5 (cg-RX-API-DMAC10.html) | ||
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2017222679A (ja) | 医薬組成物 | |
| TW200306799A (en) | Combination of organic compounds | |
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2004516266A (ja) | アムロジピンおよびベナゼブリルの治療的組み合わせ | |
| JP2007506752A (ja) | 肺動脈高血圧症を治療するための併用療法におけるイロプロスト | |
| SK12172000A3 (sk) | Farmaceutické kombinácie obsahujúce tramadol | |
| JP2023509698A5 (cg-RX-API-DMAC10.html) | ||
| JP2025511402A5 (cg-RX-API-DMAC10.html) | ||
| JPH0141608B2 (cg-RX-API-DMAC10.html) | ||
| JP2021530568A5 (cg-RX-API-DMAC10.html) | ||
| MX2013005716A (es) | Formulacion de un complejo que comprende clorhidrato de lercanidipina y valsartan y metodo para la preparacion de la misma. | |
| JP2024084670A5 (cg-RX-API-DMAC10.html) | ||
| JP2023518430A (ja) | 感染症の治療におけるブシラミンの使用 | |
| JP2022521208A5 (cg-RX-API-DMAC10.html) | ||
| JP2022542305A5 (cg-RX-API-DMAC10.html) | ||
| JP2025505294A (ja) | Ｌ－トリプトファン、ｌ－５－ヒドロキシトリプトファンおよび末梢分解阻害剤を含む医薬組成物および医薬 | |
| CZ20023322A3 (cs) | Farmakologická kombinace | |
| BE1004112A3 (fr) | Composition pharmaceutique anorexigene comprenant du 5-hydroxytryptophane | |
| TW200423929A (en) | Pharmaceutical combination | |
| KR100379155B1 (ko) | 새로운 진통제 조성물 | |
| JPH0840878A (ja) | 香りがするフイルム塗膜を含む固形医薬投与剤 |